nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Methotrexate—muscle cancer	0.249	0.314	CbGbCtD
Pioglitazone—PTGS1—Etoposide—muscle cancer	0.161	0.203	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—muscle cancer	0.145	0.183	CbGbCtD
Pioglitazone—CYP2C8—Etoposide—muscle cancer	0.0928	0.117	CbGbCtD
Pioglitazone—CYP3A4—Vincristine—muscle cancer	0.0411	0.0519	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—muscle cancer	0.0403	0.051	CbGbCtD
Pioglitazone—CYP3A4—Etoposide—muscle cancer	0.0376	0.0475	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—muscle cancer	0.0257	0.0324	CbGbCtD
Pioglitazone—PPARG—Teniposide—Etoposide—muscle cancer	0.00985	1	CbGdCrCtD
Pioglitazone—PPARG—hindlimb—muscle cancer	0.00619	0.187	CbGeAlD
Pioglitazone—PPARG—appendage—muscle cancer	0.00531	0.16	CbGeAlD
Pioglitazone—Diabetic—Methotrexate—muscle cancer	0.00336	0.0203	CcSEcCtD
Pioglitazone—Tooth abscess—Doxorubicin—muscle cancer	0.00233	0.0141	CcSEcCtD
Pioglitazone—Hepatic failure—Dactinomycin—muscle cancer	0.00209	0.0126	CcSEcCtD
Pioglitazone—SLCO1B3—vagina—muscle cancer	0.00194	0.0585	CbGeAlD
Pioglitazone—Fracture—Methotrexate—muscle cancer	0.00193	0.0117	CcSEcCtD
Pioglitazone—Multiple fractures—Methotrexate—muscle cancer	0.00193	0.0117	CcSEcCtD
Pioglitazone—Hepatic failure—Vincristine—muscle cancer	0.00187	0.0113	CcSEcCtD
Pioglitazone—Polyp—Methotrexate—muscle cancer	0.00185	0.0112	CcSEcCtD
Pioglitazone—PPARG—embryo—muscle cancer	0.00176	0.0532	CbGeAlD
Pioglitazone—Liver function test abnormal—Dactinomycin—muscle cancer	0.00174	0.0105	CcSEcCtD
Pioglitazone—Pain in extremity—Vincristine—muscle cancer	0.00168	0.0102	CcSEcCtD
Pioglitazone—Cyst—Methotrexate—muscle cancer	0.00168	0.0102	CcSEcCtD
Pioglitazone—Liver disorder—Methotrexate—muscle cancer	0.00165	0.00996	CcSEcCtD
Pioglitazone—Generalised oedema—Doxorubicin—muscle cancer	0.00163	0.00988	CcSEcCtD
Pioglitazone—Polyp—Doxorubicin—muscle cancer	0.0016	0.00966	CcSEcCtD
Pioglitazone—SLCO1B1—renal system—muscle cancer	0.00155	0.0467	CbGeAlD
Pioglitazone—Cardiac failure congestive—Etoposide—muscle cancer	0.0015	0.00907	CcSEcCtD
Pioglitazone—Cyst—Doxorubicin—muscle cancer	0.00145	0.00879	CcSEcCtD
Pioglitazone—Cardiac failure—Etoposide—muscle cancer	0.00139	0.00843	CcSEcCtD
Pioglitazone—PPARG—smooth muscle tissue—muscle cancer	0.00139	0.0419	CbGeAlD
Pioglitazone—Erectile dysfunction—Vincristine—muscle cancer	0.00134	0.00808	CcSEcCtD
Pioglitazone—PPARG—renal system—muscle cancer	0.00133	0.0403	CbGeAlD
Pioglitazone—Weight decreased—Vincristine—muscle cancer	0.00131	0.00794	CcSEcCtD
Pioglitazone—Hepatitis—Dactinomycin—muscle cancer	0.0013	0.00786	CcSEcCtD
Pioglitazone—Pharyngitis—Dactinomycin—muscle cancer	0.00129	0.0078	CcSEcCtD
Pioglitazone—Proteinuria—Methotrexate—muscle cancer	0.00128	0.00772	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Vincristine—muscle cancer	0.00128	0.00771	CcSEcCtD
Pioglitazone—Myocardial infarction—Vincristine—muscle cancer	0.00127	0.00767	CcSEcCtD
Pioglitazone—Protein urine present—Methotrexate—muscle cancer	0.00126	0.00762	CcSEcCtD
Pioglitazone—Sweating—Vincristine—muscle cancer	0.00124	0.0075	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Etoposide—muscle cancer	0.0012	0.00725	CcSEcCtD
Pioglitazone—Glycosuria—Doxorubicin—muscle cancer	0.0012	0.00725	CcSEcCtD
Pioglitazone—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00119	0.00717	CcSEcCtD
Pioglitazone—Hypoaesthesia—Vincristine—muscle cancer	0.00116	0.00699	CcSEcCtD
Pioglitazone—Urinary tract disorder—Vincristine—muscle cancer	0.00115	0.00694	CcSEcCtD
Pioglitazone—Connective tissue disorder—Vincristine—muscle cancer	0.00114	0.0069	CcSEcCtD
Pioglitazone—Urethral disorder—Vincristine—muscle cancer	0.00114	0.00688	CcSEcCtD
Pioglitazone—Cardiac disorder—Vincristine—muscle cancer	0.00108	0.00652	CcSEcCtD
Pioglitazone—Ill-defined disorder—Dactinomycin—muscle cancer	0.00105	0.00635	CcSEcCtD
Pioglitazone—Infestation—Etoposide—muscle cancer	0.00105	0.00634	CcSEcCtD
Pioglitazone—Infestation NOS—Etoposide—muscle cancer	0.00105	0.00634	CcSEcCtD
Pioglitazone—Mediastinal disorder—Vincristine—muscle cancer	0.00105	0.00633	CcSEcCtD
Pioglitazone—Anaemia—Dactinomycin—muscle cancer	0.00105	0.00632	CcSEcCtD
Pioglitazone—PPARG—tendon—muscle cancer	0.00104	0.0315	CbGeAlD
Pioglitazone—Acute coronary syndrome—Etoposide—muscle cancer	0.00103	0.00625	CcSEcCtD
Pioglitazone—Myocardial infarction—Etoposide—muscle cancer	0.00103	0.00621	CcSEcCtD
Pioglitazone—Malaise—Dactinomycin—muscle cancer	0.00102	0.00617	CcSEcCtD
Pioglitazone—Neoplasm—Methotrexate—muscle cancer	0.00102	0.00614	CcSEcCtD
Pioglitazone—PPARG—bone marrow—muscle cancer	0.00101	0.0305	CbGeAlD
Pioglitazone—Pulmonary oedema—Methotrexate—muscle cancer	0.000999	0.00604	CcSEcCtD
Pioglitazone—Back pain—Vincristine—muscle cancer	0.000978	0.00591	CcSEcCtD
Pioglitazone—PPARG—vagina—muscle cancer	0.000967	0.0292	CbGeAlD
Pioglitazone—Myalgia—Dactinomycin—muscle cancer	0.000964	0.00583	CcSEcCtD
Pioglitazone—Discomfort—Dactinomycin—muscle cancer	0.000952	0.00576	CcSEcCtD
Pioglitazone—Diabetes mellitus—Methotrexate—muscle cancer	0.000937	0.00566	CcSEcCtD
Pioglitazone—Hypoaesthesia—Etoposide—muscle cancer	0.000936	0.00566	CcSEcCtD
Pioglitazone—Anaemia—Vincristine—muscle cancer	0.000935	0.00565	CcSEcCtD
Pioglitazone—Urinary tract disorder—Etoposide—muscle cancer	0.00093	0.00562	CcSEcCtD
Pioglitazone—Oedema—Dactinomycin—muscle cancer	0.000924	0.00558	CcSEcCtD
Pioglitazone—Fluid retention—Doxorubicin—muscle cancer	0.000923	0.00558	CcSEcCtD
Pioglitazone—Urethral disorder—Etoposide—muscle cancer	0.000923	0.00558	CcSEcCtD
Pioglitazone—Infection—Dactinomycin—muscle cancer	0.000918	0.00555	CcSEcCtD
Pioglitazone—Vertigo—Vincristine—muscle cancer	0.000909	0.00549	CcSEcCtD
Pioglitazone—Hepatic failure—Methotrexate—muscle cancer	0.000907	0.00548	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000893	0.0054	CcSEcCtD
Pioglitazone—PPARG—head—muscle cancer	0.000893	0.027	CbGeAlD
Pioglitazone—CYP2C8—renal system—muscle cancer	0.00088	0.0266	CbGeAlD
Pioglitazone—Eye disorder—Etoposide—muscle cancer	0.00088	0.00532	CcSEcCtD
Pioglitazone—Neoplasm—Doxorubicin—muscle cancer	0.000879	0.00531	CcSEcCtD
Pioglitazone—Cardiac disorder—Etoposide—muscle cancer	0.000874	0.00528	CcSEcCtD
Pioglitazone—Hypertension—Vincristine—muscle cancer	0.000873	0.00528	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—muscle cancer	0.000865	0.00523	CcSEcCtD
Pioglitazone—PPARG—testis—muscle cancer	0.000863	0.026	CbGeAlD
Pioglitazone—Myalgia—Vincristine—muscle cancer	0.000861	0.00521	CcSEcCtD
Pioglitazone—Visual disturbance—Methotrexate—muscle cancer	0.00086	0.0052	CcSEcCtD
Pioglitazone—Immune system disorder—Etoposide—muscle cancer	0.00085	0.00514	CcSEcCtD
Pioglitazone—Mediastinal disorder—Etoposide—muscle cancer	0.000848	0.00513	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—muscle cancer	0.000848	0.00512	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000842	0.00509	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Methotrexate—muscle cancer	0.000832	0.00503	CcSEcCtD
Pioglitazone—Oedema—Vincristine—muscle cancer	0.000825	0.00499	CcSEcCtD
Pioglitazone—Anaphylactic shock—Vincristine—muscle cancer	0.000825	0.00499	CcSEcCtD
Pioglitazone—Infection—Vincristine—muscle cancer	0.00082	0.00496	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—muscle cancer	0.000811	0.0049	CcSEcCtD
Pioglitazone—Nervous system disorder—Vincristine—muscle cancer	0.00081	0.00489	CcSEcCtD
Pioglitazone—Hyperhidrosis—Vincristine—muscle cancer	0.000798	0.00482	CcSEcCtD
Pioglitazone—Fatigue—Dactinomycin—muscle cancer	0.000797	0.00481	CcSEcCtD
Pioglitazone—Back pain—Etoposide—muscle cancer	0.000793	0.00479	CcSEcCtD
Pioglitazone—Muscle spasms—Etoposide—muscle cancer	0.000788	0.00476	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—muscle cancer	0.000785	0.00475	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000778	0.0047	CcSEcCtD
Pioglitazone—Feeling abnormal—Dactinomycin—muscle cancer	0.000761	0.0046	CcSEcCtD
Pioglitazone—Ill-defined disorder—Etoposide—muscle cancer	0.00076	0.0046	CcSEcCtD
Pioglitazone—Anaemia—Etoposide—muscle cancer	0.000757	0.00458	CcSEcCtD
Pioglitazone—Liver function test abnormal—Methotrexate—muscle cancer	0.000752	0.00455	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000752	0.00455	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—muscle cancer	0.000751	0.00454	CcSEcCtD
Pioglitazone—Insomnia—Vincristine—muscle cancer	0.000747	0.00451	CcSEcCtD
Pioglitazone—PTGS1—smooth muscle tissue—muscle cancer	0.000741	0.0224	CbGeAlD
Pioglitazone—Malaise—Etoposide—muscle cancer	0.000739	0.00447	CcSEcCtD
Pioglitazone—Breast disorder—Methotrexate—muscle cancer	0.000736	0.00445	CcSEcCtD
Pioglitazone—Vertigo—Etoposide—muscle cancer	0.000736	0.00445	CcSEcCtD
Pioglitazone—CYP2C19—vagina—muscle cancer	0.00073	0.022	CbGeAlD
Pioglitazone—Hypoglycaemia—Doxorubicin—muscle cancer	0.000723	0.00437	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—muscle cancer	0.000723	0.00437	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00072	0.00435	CcSEcCtD
Pioglitazone—PTGS1—renal system—muscle cancer	0.000713	0.0215	CbGeAlD
Pioglitazone—Gastrointestinal disorder—Vincristine—muscle cancer	0.000713	0.00431	CcSEcCtD
Pioglitazone—Fatigue—Vincristine—muscle cancer	0.000712	0.0043	CcSEcCtD
Pioglitazone—Hypertension—Etoposide—muscle cancer	0.000707	0.00428	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—muscle cancer	0.000706	0.00427	CcSEcCtD
Pioglitazone—Chest pain—Etoposide—muscle cancer	0.000698	0.00422	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000693	0.00419	CcSEcCtD
Pioglitazone—Discomfort—Etoposide—muscle cancer	0.000689	0.00417	CcSEcCtD
Pioglitazone—Hypersensitivity—Dactinomycin—muscle cancer	0.000681	0.00411	CcSEcCtD
Pioglitazone—Anaphylactic shock—Etoposide—muscle cancer	0.000669	0.00404	CcSEcCtD
Pioglitazone—Infection—Etoposide—muscle cancer	0.000664	0.00402	CcSEcCtD
Pioglitazone—Asthenia—Dactinomycin—muscle cancer	0.000663	0.00401	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000655	0.00396	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—muscle cancer	0.000651	0.00394	CcSEcCtD
Pioglitazone—Skin disorder—Etoposide—muscle cancer	0.00065	0.00393	CcSEcCtD
Pioglitazone—Erectile dysfunction—Methotrexate—muscle cancer	0.000649	0.00392	CcSEcCtD
Pioglitazone—Hyperhidrosis—Etoposide—muscle cancer	0.000646	0.00391	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—muscle cancer	0.000645	0.0039	CcSEcCtD
Pioglitazone—PTGS1—cardiac atrium—muscle cancer	0.000639	0.0193	CbGeAlD
Pioglitazone—Breast disorder—Doxorubicin—muscle cancer	0.000638	0.00385	CcSEcCtD
Pioglitazone—CYP2C8—vagina—muscle cancer	0.000637	0.0192	CbGeAlD
Pioglitazone—Diarrhoea—Dactinomycin—muscle cancer	0.000632	0.00382	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—muscle cancer	0.000628	0.0038	CcSEcCtD
Pioglitazone—Infestation NOS—Methotrexate—muscle cancer	0.000628	0.0038	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000622	0.00376	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—muscle cancer	0.00061	0.00369	CcSEcCtD
Pioglitazone—Hypersensitivity—Vincristine—muscle cancer	0.000608	0.00368	CcSEcCtD
Pioglitazone—Sweating—Methotrexate—muscle cancer	0.000602	0.00364	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—muscle cancer	0.000599	0.00362	CcSEcCtD
Pioglitazone—Dyspnoea—Etoposide—muscle cancer	0.000596	0.0036	CcSEcCtD
Pioglitazone—CYP3A4—renal system—muscle cancer	0.000596	0.018	CbGeAlD
Pioglitazone—Angina pectoris—Doxorubicin—muscle cancer	0.000594	0.00359	CcSEcCtD
Pioglitazone—Asthenia—Vincristine—muscle cancer	0.000592	0.00358	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—muscle cancer	0.000587	0.00355	CcSEcCtD
Pioglitazone—CYP2D6—renal system—muscle cancer	0.000586	0.0177	CbGeAlD
Pioglitazone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000577	0.00349	CcSEcCtD
Pioglitazone—Fatigue—Etoposide—muscle cancer	0.000577	0.00348	CcSEcCtD
Pioglitazone—CYP2C8—testis—muscle cancer	0.000569	0.0172	CbGeAlD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000567	0.00343	CcSEcCtD
Pioglitazone—Diarrhoea—Vincristine—muscle cancer	0.000565	0.00341	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—muscle cancer	0.000564	0.00341	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—muscle cancer	0.00056	0.00338	CcSEcCtD
Pioglitazone—PTGS1—tendon—muscle cancer	0.000557	0.0168	CbGeAlD
Pioglitazone—Urinary tract disorder—Methotrexate—muscle cancer	0.000557	0.00337	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—muscle cancer	0.000555	0.00336	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—muscle cancer	0.000553	0.00334	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—muscle cancer	0.000552	0.00334	CcSEcCtD
Pioglitazone—Feeling abnormal—Etoposide—muscle cancer	0.000551	0.00333	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—muscle cancer	0.00055	0.00333	CcSEcCtD
Pioglitazone—Dizziness—Vincristine—muscle cancer	0.000546	0.0033	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—muscle cancer	0.000544	0.00329	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—muscle cancer	0.000544	0.00329	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—muscle cancer	0.000543	0.00328	CcSEcCtD
Pioglitazone—Urticaria—Etoposide—muscle cancer	0.000531	0.00321	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—muscle cancer	0.000529	0.0032	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—muscle cancer	0.000527	0.00318	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—muscle cancer	0.000523	0.00316	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—muscle cancer	0.000521	0.00315	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—muscle cancer	0.000518	0.00313	CcSEcCtD
Pioglitazone—Headache—Vincristine—muscle cancer	0.000517	0.00313	CcSEcCtD
Pioglitazone—PTGS1—vagina—muscle cancer	0.000517	0.0156	CbGeAlD
Pioglitazone—Sinusitis—Doxorubicin—muscle cancer	0.00051	0.00308	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—muscle cancer	0.000509	0.00308	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—muscle cancer	0.000508	0.00307	CcSEcCtD
Pioglitazone—Hypersensitivity—Etoposide—muscle cancer	0.000493	0.00298	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—muscle cancer	0.000491	0.00297	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—muscle cancer	0.000488	0.00295	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000486	0.00294	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—muscle cancer	0.000485	0.00293	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—muscle cancer	0.000482	0.00291	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—muscle cancer	0.000481	0.00291	CcSEcCtD
Pioglitazone—Asthenia—Etoposide—muscle cancer	0.00048	0.0029	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—muscle cancer	0.00048	0.0029	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—muscle cancer	0.000479	0.00289	CcSEcCtD
Pioglitazone—PTGS1—head—muscle cancer	0.000477	0.0144	CbGeAlD
Pioglitazone—Back pain—Methotrexate—muscle cancer	0.000475	0.00287	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—muscle cancer	0.00047	0.00284	CcSEcCtD
Pioglitazone—PTGS1—testis—muscle cancer	0.000461	0.0139	CbGeAlD
Pioglitazone—Diarrhoea—Etoposide—muscle cancer	0.000458	0.00277	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—muscle cancer	0.000456	0.00276	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methotrexate—muscle cancer	0.000455	0.00275	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—muscle cancer	0.000454	0.00274	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—muscle cancer	0.000453	0.00274	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—muscle cancer	0.000443	0.00268	CcSEcCtD
Pioglitazone—Dizziness—Etoposide—muscle cancer	0.000442	0.00267	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—muscle cancer	0.000441	0.00267	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—muscle cancer	0.000441	0.00267	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—muscle cancer	0.00044	0.00266	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—muscle cancer	0.000425	0.00257	CcSEcCtD
Pioglitazone—Headache—Etoposide—muscle cancer	0.000419	0.00253	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—muscle cancer	0.000419	0.00253	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—muscle cancer	0.000418	0.00253	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—muscle cancer	0.000418	0.00253	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—muscle cancer	0.000418	0.00253	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000415	0.00251	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—muscle cancer	0.000413	0.0025	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—muscle cancer	0.000411	0.00248	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—muscle cancer	0.000409	0.00247	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—muscle cancer	0.000401	0.00242	CcSEcCtD
Pioglitazone—Infection—Methotrexate—muscle cancer	0.000398	0.00241	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000394	0.00238	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—muscle cancer	0.000393	0.00237	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—muscle cancer	0.000393	0.00237	CcSEcCtD
Pioglitazone—CYP2D6—head—muscle cancer	0.000392	0.0118	CbGeAlD
Pioglitazone—Skin disorder—Methotrexate—muscle cancer	0.000389	0.00235	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—muscle cancer	0.000387	0.00234	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—muscle cancer	0.000383	0.00232	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—muscle cancer	0.000382	0.00231	CcSEcCtD
Pioglitazone—CYP2D6—testis—muscle cancer	0.000379	0.0114	CbGeAlD
Pioglitazone—Hypertension—Doxorubicin—muscle cancer	0.000367	0.00222	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000365	0.00221	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—muscle cancer	0.000362	0.00219	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—muscle cancer	0.000362	0.00219	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—muscle cancer	0.000362	0.00219	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—muscle cancer	0.000362	0.00219	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000359	0.00217	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—muscle cancer	0.000357	0.00216	CcSEcCtD
Pioglitazone—Dyspnoea—Methotrexate—muscle cancer	0.000357	0.00216	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—muscle cancer	0.000347	0.0021	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000347	0.0021	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000346	0.00209	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—muscle cancer	0.000345	0.00209	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—muscle cancer	0.000345	0.00208	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—muscle cancer	0.00034	0.00206	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—muscle cancer	0.000337	0.00204	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000335	0.00203	CcSEcCtD
Pioglitazone—Feeling abnormal—Methotrexate—muscle cancer	0.00033	0.002	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—muscle cancer	0.000318	0.00192	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000316	0.00191	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—muscle cancer	0.000314	0.0019	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—muscle cancer	0.000309	0.00187	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000299	0.00181	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—muscle cancer	0.000299	0.00181	CcSEcCtD
Pioglitazone—Hypersensitivity—Methotrexate—muscle cancer	0.000295	0.00178	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—muscle cancer	0.000287	0.00174	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—muscle cancer	0.000286	0.00173	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—muscle cancer	0.000276	0.00167	CcSEcCtD
Pioglitazone—Diarrhoea—Methotrexate—muscle cancer	0.000274	0.00166	CcSEcCtD
Pioglitazone—Dizziness—Methotrexate—muscle cancer	0.000265	0.0016	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—muscle cancer	0.000256	0.00154	CcSEcCtD
Pioglitazone—Headache—Methotrexate—muscle cancer	0.000251	0.00152	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—muscle cancer	0.000249	0.0015	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—muscle cancer	0.000237	0.00143	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—muscle cancer	0.000229	0.00139	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—muscle cancer	0.000217	0.00131	CcSEcCtD
